The future in the instant: The lung adenocarcinoma classification as a predictor of future adverse events
Lung Cancer
.
2021 May:155:191-192.
doi: 10.1016/j.lungcan.2021.03.010.
Epub 2021 Mar 16.
Author
Raymond U Osarogiagbon
1
Affiliation
1
Multidisciplinary Thoracic Oncology Program, Baptist Cancer Center, 80 Humphreys Center Drive, Suite 330, Memphis, TN, USA. Electronic address: rosarogi@bmhcc.org.
PMID:
33757658
DOI:
10.1016/j.lungcan.2021.03.010
No abstract available
Publication types
Editorial
Research Support, N.I.H., Extramural
Comment
MeSH terms
Adenocarcinoma of Lung* / diagnosis
Adenocarcinoma* / diagnosis
Brain Neoplasms*
Humans
Lung Neoplasms* / diagnosis
Neoplasms, Second Primary*
Grants and funding
UG1 CA189873/CA/NCI NIH HHS/United States
UM1 CA233080/CA/NCI NIH HHS/United States
R01 CA172253/CA/NCI NIH HHS/United States